Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors

被引：12

作者：

Firooznia, F ^{[1
]}

Gude, C ^{[1
]}

Chan, K ^{[1
]}

Fink, CA ^{[1
]}

Qiao, Y ^{[1
]}

Satoh, Y ^{[1
]}

Marcopoulos, N ^{[1
]}

Savage, P ^{[1
]}

Beil, ME ^{[1
]}

Bruseo, CW ^{[1
]}

Trapani, AJ ^{[1
]}

Jeng, AY ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 03期

关键词：

D O I：

10.1016/S0960-894X(00)00657-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Through directed screening of metalloprotease inhibitors. CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in vitro (IC50 = 77 nM). Herein we report the synthesis and biological activities of analogues derived from this lead. based on modifications of the biphenyl moiety. Compound 10. the thioacetate methyl ester prodrug derivative of compound 6m. was found to he an orally active and potent inhibitor of ECE-1 activity in rats. (C) 2001 Elsevier science Ltd. All rights reserved.

引用

页码：375 / 378

页数：4

共 50 条

[31] Cyclosporine A induces endothelin-converting enzyme-1: Studies invivo and invitro
Heyman, S. N.
Abassi, Z.
Rosenberger, C.
Yaseen, H.
Skarjinski, G.
Shina, A.
Mathia, S.
Krits, N.
Khamaisi, M.
ACTA PHYSIOLOGICA, 2018, 223 (01)
[32] Endothelin-converting enzyme-1 degrades internalized somatostatin-14
Roosterman, Dirk
Kempkes, Cordula
Cottrell, Graeme S.
Padilla, Benjamin E.
Bunnett, Nigel W.
Turck, Christoph W.
Steinhoff, Martin
ENDOCRINOLOGY, 2008, 149 (05) : 2200 - 2207
[33] Expression and localization of endothelin-converting enzyme-1 in human prostate cancer
Dawson, Louise A.
Maitland, Norman J.
Berry, Paul
Turner, Anthony J.
Usmani, Badar A.
EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 1106 - 1110
[34] Induction of endothelin-converting enzyme-1 in gastric mucosal injury by idomethacin
Slomiany, BL
Slomiany, A
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 377 - 381
[35] Characterization of human endothelin-converting enzyme-1 cellular distribution.
Pinet, F
Korth, P
Bohle, RM
Corvol, P
HYPERTENSION, 1998, 32 (04) : 795 - 795
[36] Hydrolysis of peptide hormones by endothelin-converting enzyme-1 - A comparison with neprilysin
Johnson, GD
Stevenson, T
Ahn, KH
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4053 - 4058
[37] Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells
Berger, Y
Delmilow, HI
Blum-Kaelin, D
Kitas, EA
Löffler, BM
Aebi, JD
Juillerat-Jeanneret, L
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 483 - 498
[38] Thiol inhibitors of endothelin-converting enzyme
Deprez, P
Guillaume, J
Dumas, J
Vevert, JP
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (19) : 2317 - 2322
[39] ENDOTHELIN-1-INDUCED PRURITUS IS REGULATED BY ENDOTHELIN-CONVERTING ENZYME-1 IN MICE AND HUMANS
Kempkes, Cordula
Buddenkotte, Joerg
Kido, Makiko
Cevikbas, Ferda
Buhl, Timo
Akiyama, Tasuku
Nunes, Frank
Seeliger, Stephan
Hasdemir, Burcu
Mess, Christian
Mueller, Frank-Ulrich
Metze, Dieter
Bhargava, Aditi
Furue, Masutaka
Carstens, Earl
Steinhoff, Martin
ACTA DERMATO-VENEREOLOGICA, 2013, 93 (05) : 625 - 625
[40] Immunohistochemical localization of endothelin-1 and endothelin-converting enzyme-1 in rat lung allografts
McDermott, CD
Shennib, H
Giaid, A
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S27 - S30

← 1 2 3 4 5 →